SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001218460-10-000002
Filing Date
2010-10-25
Accepted
2010-10-25 15:08:25
Documents
1
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 6154
  Complete submission text file 0001218460-10-000002.txt   8197
Mailing Address PO BOX 87721 HOUSTON TX 77287
Business Address
CASEY KEVAN (Reporting) CIK: 0001218460 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-50541 | Film No.: 101139754

Mailing Address 710 POST OAK SUITE 410 HOUSTON TX 77024
Business Address 710 POST OAK SUITE 410 HOUSTON TX 77024 713-780-0806
Oncolin Therapeutics, Inc. (Issuer) CIK: 0001229089 (see all company filings)

IRS No.: 880507007 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations